# Junta clínica — PT-pseudo_5dc2eb70fbd7 (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_5dc2eb70fbd7",
  "pid": "PT-pseudo_5dc2eb70fbd7",
  "task": 1,
  "psa": 0.44,
  "age": 63,
  "months": 1,
  "pirads": "3",
  "psad": 0.03,
  "psav": 0.0,
  "psap": 0.4,
  "vol": 29.0,
  "dre": "Normal",
  "bx": "Negative",
  "cspca": 0.57961565,
  "medhx": "Hypertension, Hypercholesterolaemia, Osteoarthritis",
  "meds": "amlodipine, lisinopril, metoprolol, atorvastatin, paracetamol PRN",
  "notes": "PSA 0.44 ng/mL. PI-RADS 3. PSAD 0.03. Prostate volume 29 mL. csPCa 0.58.",
  "pmhx": [
    "Hypertension",
    "Hypercholesterolaemia",
    "Osteoarthritis"
  ],
  "allergies": [],
  "vitals": {
    "weight": "84 kg",
    "height": "179 cm",
    "bmi": "26.2",
    "bp": "142/80 mmHg",
    "hr": "67 bpm",
    "smoking": "Current smoker (36 pack-yr)",
    "last_dental": "2 yr ago",
    "flu_vax": "Sep 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "09 Feb 2025",
  "enc_ref": "Dr. C. Peters (GP)",
  "enc_type": "Re-evaluation - prior negative biopsy",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Persistent uncertainty regarding prostate cancer screening warrants re-evaluation after an earlier negative biopsy and a steady PSA course."
    },
    {
      "s": "History",
      "t": "A 63-year-old civil engineer initially entered evaluation years ago after a mildly elevated PSA triggered a systematic biopsy that returned entirely benign. He currently experiences moderate lower urinary tract symptoms, notably nocturia twice nightly and a slightly weak stream, yielding an IPSS score of 10. Medical background includes well-controlled hypertension and hypercholesterolaemia, treated with amlodipine, lisinopril, metoprolol, and atorvastatin, plus occasional paracetamol PRN for osteoarthritis. He maintains a 36 pack-year smoking history and drinks roughly 26 units of alcohol weekly. Daily fitness routines include a 20-minute walk. Beyond urological matters, he recently finished six physiotherapy sessions for mechanical lower back pain, keeps up with regular dental check-ups, and manages mild visual impairment requiring large-print materials. He lives with his wife; their adult children visit weekly, and he continues active involvement in local engineering consultancy projects."
    },
    {
      "s": "Physical examination",
      "t": "DRE — texture: smooth and symmetric; consistency: normal; asymmetry/nodules: absent. Vital signs reveal a blood pressure of 142/80 mmHg and a regular heart rate of 67 beats per minute. General inspection shows no peripheral oedema, while abdominal palpation confirms the absence of suprapubic tenderness or palpable masses."
    }
  ],
  "occupation": "civil engineer",
  "marital": "Married",
  "living": "Lives with partner; adult children visit weekly",
  "next_of_kin": "Sibling (sister)",
  "recent_other": [
    "Physiotherapy — lower back, six sessions",
    "Dental — biannual check-up"
  ],
  "alcohol": "26 units / week",
  "exercise": "Walking 20 min/day",
  "ipss": "IPSS score: 10/35 (moderate LUTS)",
  "admin": "Visual impairment: large-print correspondence requested.",
  "mri_hospital": "Spaarne Gasthuis (Haarlem)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_5dc2eb70fbd7
Task: 1

Encounter: Urology - outpatient on 09 Feb 2025.
Referrer: Dr. C. Peters (GP).
Type: Re-evaluation - prior negative biopsy.

Clinical data (read-only — values loaded from the record):
  - 63-year-old male
  - PSA: 0.44 ng/mL
  - mpMRI — PI-RADS score: 3 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.03 ng/mL²
  - PSA velocity: 0.0 ng/mL/yr
  - Prior PSA: 0.4 ng/mL
  - Prostate volume: 29.0 mL
  - Months since last PSA: 1
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Negative (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.57961565 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Hypertension, Hypercholesterolaemia, Osteoarthritis
  - Problem list / PMHx: Hypertension, Hypercholesterolaemia, Osteoarthritis
  - Current medication: amlodipine, lisinopril, metoprolol, atorvastatin, paracetamol PRN
  - Allergies: NKA
  - Additional notes: PSA 0.44 ng/mL. PI-RADS 3. PSAD 0.03. Prostate volume 29 mL. csPCa 0.58.

Vitals: weight 84 kg, height 179 cm, BMI 26.2, BP 142/80 mmHg, HR 67 bpm. Smoking: Current smoker (36 pack-yr).

Chief complaint: Persistent uncertainty regarding prostate cancer screening warrants re-evaluation after an earlier negative biopsy and a steady PSA course.

History: A 63-year-old civil engineer initially entered evaluation years ago after a mildly elevated PSA triggered a systematic biopsy that returned entirely benign. He currently experiences moderate lower urinary tract symptoms, notably nocturia twice nightly and a slightly weak stream, yielding an IPSS score of 10. Medical background includes well-controlled hypertension and hypercholesterolaemia, treated with amlodipine, lisinopril, metoprolol, and atorvastatin, plus occasional paracetamol PRN for osteoarthritis. He maintains a 36 pack-year smoking history and drinks roughly 26 units of alcohol weekly. Daily fitness routines include a 20-minute walk. Beyond urological matters, he recently finished six physiotherapy sessions for mechanical lower back pain, keeps up with regular dental check-ups, and manages mild visual impairment requiring large-print materials. He lives with his wife; their adult children visit weekly, and he continues active involvement in local engineering consultancy projects.

Physical examination: DRE — texture: smooth and symmetric; consistency: normal; asymmetry/nodules: absent. Vital signs reveal a blood pressure of 142/80 mmHg and a regular heart rate of 67 beats per minute. General inspection shows no peripheral oedema, while abdominal palpation confirms the absence of suprapubic tenderness or palpable masses.

Patient info: civil engineer; Married; Lives with partner; adult children visit weekly.
Next of kin: Sibling (sister).

Lifestyle: alcohol 26 units / week; exercise Walking 20 min/day; IPSS score: 10/35 (moderate LUTS).

Recent other appointments: Physiotherapy — lower back, six sessions; Dental — biannual check-up.
Admin: Visual impairment: large-print correspondence requested.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: NO BIOPSY   p(biopsy) = 0.43
  uncertainty  +/- 0.13 epistemic (95% band 0.18-0.68); among patients I cannot tell apart the outcome was 0.99 of 1.00 mixed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = Negative (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = 3 on the problem list (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 63 (2% of my signal; from age) · DRE = Normal (10% of my signal; from dre_suspicious) · PSA = 0.44 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 29 mL (1% of my signal; from log_vol, vol) · PSA density = 0.03 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.58 (1% of my signal; from cspca) · PI-RADS = 3 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior negative biopsy. My criterion answers DEFER.

The criterion: repeat, targeted, when the mpMRI shows a PI-RADS 4-5 lesion; do not repeat a negative biopsy for an unchanged PI-RADS 3 or lower picture. In the labelled series this criterion matched the reading urologist in 16 of 18 cases in exactly this situation.

Like Expert 1, I have read ONLY the visible panel — not the mpMRI prose, the PSA trajectory, the
previous notes or the laboratory panel. Departing from me needs a specific finding from a document
somebody actually opened, named out loud; not a restatement of the panel numbers I already used.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  decisive   PI-RADS = 3
  important  prior biopsy = Negative
  noted      age = 63 · DRE = Normal · PSA = 0.44 ng/mL · prostate volume = 29 mL · PSA density = 0.03 · comorbidity = 3 on the problem list
  not used   family history, csPCa probability
CONFIDENCE: borderline — the rule matched the reading urologist in 16 of 18 labelled cases

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 18 labelled men in this same situation (Negative prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 2.07: PI-RADS 4, PSA 0.76, PSAD 0.02, age 60, DRE Normal -> DEFER (clear). He wrote: "Low PSA with earlier negative biopsy. A change in P4 lesion size might trigger a biopsy."
  2. distance 2.55: PI-RADS 3, PSA 3.4, PSAD 0.05, age 63, DRE Normal -> DEFER (clear). He wrote: "Prev benign biopsy + PIRADS 3 (=no significant lesion) + low PSA-density -> Low longterm risk of lethal prostate cancer. 2yr too short interval for next assessment. sugg…"
  3. distance 3.31: PI-RADS 4, PSA 3.0, PSAD 0.12, age 68, DRE Normal -> BIOPSY (borderline). He wrote: "PIRADS 4 lesion in 68 year old man with heavy comorbidity. Earlier negative biopsy."

PRECEDENT: DEFER (weighted vote 0.26 for biopsy). Distance-weighted precedent is fair here (0.78 leave-one-out).

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  important  prior biopsy = Negative · age = 63 · PSA = 0.44 ng/mL · PI-RADS = 3
  noted      family history = not opened (0 of 91) · DRE = Normal · prostate volume = 29 mL · PSA density = 0.03 · comorbidity = 3 on the problem list
  not used   csPCa probability
CONFIDENCE: borderline — the library is right 78% of the time in this situation out of fold

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 18 labelled traces in this situation (Negative prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes, laboratory_results.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  important  prior biopsy = Negative · age = 63 · PSA = 0.44 ng/mL · PI-RADS = 3
  noted      family history = not opened (0 of 91) · DRE = Normal · prostate volume = 29 mL · PSA density = 0.03 · comorbidity = 3 on the problem list
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The EAU guidelines suggest that a PI-RADS threshold of $\ge 3$ is used to trigger a biopsy. The guideline states: "a PI-RADS threshold of $\ge 3$ is used to trigger biopsy [135, 226, 264, 375], at the cost of missing a small number of mainly ISUP GG 2 cancers, especially in biopsy-naïve patients or in highly selected populations with high prevalence of csPCa (in which the MRI NPV decreases) [372, 472]."

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, your variable 'prior biopsy = Negative' is decisive, whereas the guideline treats it as context. The guideline suggests that a PI-RADS threshold of $\ge 3$ is used to trigger biopsy, regardless of prior biopsy status. The guideline requires a comparison MRI to guide the decision, which is a fact the panel does not represent.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the prior biopsy status: Negative means the guideline suggests considering follow-up or direct repeat biopsy depending on risk factors.
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does
psa_trend - the PSA trend: The guideline requires this to assess risk factors for repeat biopsy.
laboratory_results - the laboratory results: The guideline requires these to assess PSA density for risk stratification.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case hinges on whether the PI-RADS 3 finding, combined with the negative prior biopsy, warrants a repeat biopsy according to the EAU guidelines.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Does the mpMRI prose indicate whether the lesion is compared against an earlier study?
  psa_trend (get_psa_trend) -> What is the PSA trend (rising, flat, or falling)?
  previous_notes (get_previous_notes) -> What is the management context regarding the prior biopsy status?
  laboratory_results (get_lab_results) -> What is the PSA density finding?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the comparison MRI status as described in the radiology_report?
  Q2. What is the PSA trend as described in the psa_trend?
  Q3. What is the management context regarding the prior biopsy status as described in the previous_notes?
  Q4. What is the PSA density as described in the laboratory_results?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
Subject: Multiparametric MRI Prostate
Facility: Spaarne Gasthuis, Haarlem
Date: 28 Jan 2025
Does the mpMRI prose indicate whether the lesion is compared against an earlier study?
"Clinical Indication: Prostate cancer screening re-evaluation. PSA 0.44 ng/mL, prior negative biopsy."

psa_trend
What is the PSA trend (rising, flat, or falling)?
PSA trend: PSA 0.5 (Apr 2022), PSA 0.5 (Apr 2023), PSA 0.5 (Mar 2024), PSA 0.5 (Feb 2025).

previous_notes
What is the management context regarding the prior biopsy status as described in the previous_notes?
"Initial prostate cancer risk assessment continues following first-line PSA screening. A March 2024 repeat test showed a stable PSA of 0.4 ng/mL alongside an absence of acute urinary complaints or digital rectal irregularities. The ongoing clinical question, combined with the patient's desire for definitive risk stratification, led to a urology scheduling for specialist re-evaluation."

laboratory_results
What is the PSA density as described in the laboratory_results?
"%Free PSA" is "13%" on "21 Jan 2025".

WHAT I DID NOT OPEN
family-history anamnesis, as it was not requested by the moderator and is not critical to the immediate decision based on the opened documents.

WHAT THIS SUPPORTS
FOR sampling this patient now
PI-RADS 3 finding from radiology_report, as the EAU guideline suggests a PI-RADS threshold of $\ge 3$ is used to trigger biopsy.
previous_notes context, as the management context indicates a desire for definitive risk stratification following a negative biopsy.

AGAINST sampling this patient now
PI-RADS 3 finding from EXPERT-COHORT, as the criterion suggests deferral when the mpMRI shows a PI-RADS 3 or lower picture.

WHERE THIS LEANS
LEAN: defer

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: INDETERMINATE (uncertain). Last value 0.50 ng/mL over 4 points spanning 34 months; velocity +0.00 ng/mL per year; no meaningful doubling time.
PROJECTION at 6 months: 0.5 ng/mL, conformal 95% band 0.1-1.7.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 0.44 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: uncertain — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report and the laboratory panel; nothing from the previous notes or the PSA series.

SUGGESTION: NO BIOPSY   p(biopsy) = 0.32
  uncertainty  +/- 0.12 epistemic (95% band 0.09-0.56), of which 0.00 comes from values that had to be imputed
  reliability  MODERATE ('supports' tier) — out-of-fold it was right 71% of the time over the 24 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = Negative (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 3 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      DRE = Normal (5% of my signal; from dre_suspicious) · PSA = 0.44 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 29 mL (4% of my signal; from log_vol, vol) · PSA density = 0.03 (0% of my signal; from psad_calc) · comorbidity = 3 on the problem list (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, csPCa probability
CONFIDENCE: borderline — 'supports' tier; out-of-fold it was right 71% of the time over the 24 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  DEFER, p(biopsy)=0.43  ('discuss' tier; weight 1.0)
  EXPERT-FUSION      DEFER, p(biopsy)=0.32  ('supports' tier, fusion_full; weight 3.0)
  EXPERT-LIBRARY     DEFER, p(biopsy)=0.26  (k=3 precedents; does not vote)
  EXPERT-COHORT      DEFER  (rule pirads_le_3; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: cohort criterion (pirads_le_3) — carried by EXPERT-COHORT.
PANEL ANSWER: NO BIOPSY. It matched the reading urologist in 16 of 18 labelled cases in exactly this situation (prior negative biopsy).

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           Negative                     E1:DEC E3:DEC cohort:IMP library:IMP E2:—            -> important
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:not E2:—                  -> not_used (raised from noted by the board)
  age          63                           E1:not E3:— cohort:not library:IMP E2:—              -> important
  dre          Normal                       E1:not E3:not cohort:not library:not E2:—            -> noted
  psa          0.44 ng/mL                   E1:not E3:not cohort:not library:IMP E2:not          -> important
  vol          29 mL                        E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.03                         E1:not E3:not cohort:not library:not E2:—            -> noted
  cspca        0.58                         E1:not E3:— cohort:— library:— E2:—                  -> not_used
  pirads       3                            E1:not E3:IMP cohort:DEC library:IMP E2:—            -> important
  comorbidity  3 on the problem list        E1:IMP E3:not cohort:not library:not E2:—            -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: clear.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened appear to answer the moderator's questions, as the trace model listed all necessary documents, and the registrar reported findings for all four questions.

ALIGNMENT WITH THE PANEL
The retrieved evidence aligns with the PANEL-PROTOCOL's answer of NO BIOPSY, as the cohort criterion (PI-RADS $\le 3$) fired, which is the rule that led to the panel's decision.

THE OPEN QUESTIONS, ONE BY ONE
Q1. The comparison MRI status is described in the radiology_report as: "Clinical Indication: Prostate cancer screening re-evaluation. PSA 0.44 ng/mL, prior negative biopsy."
Q2. The PSA trend is described in the psa_trend as: "PSA trend: PSA 0.5 (Apr 2022), PSA 0.5 (Apr 2023), PSA 0.5 (Mar 2024), PSA 0.5 (Feb 2025)."
Q3. The management context regarding the prior biopsy status is described in the previous_notes as: "Initial prostate cancer risk assessment continues following first-line PSA screening. A March 2024 repeat test showed a stable PSA of 0.4 ng/mL alongside an absence of acute urinary complaints or digital rectal irregularities. The ongoing clinical question, combined with the patient's desire for definitive risk stratification, led to a urology scheduling for specialist re-evaluation."
Q4. The PSA density is described in the laboratory_results as: "%Free PSA" is "13%" on "21 Jan 2025".

WHAT CARRIES WEIGHT, AND WHY
<pirads>: decisive: 3 (The PI-RADS 3 finding is decisive because the cohort criterion fired, which is the rule that led to the panel's decision, and the EXPERT-COHORT marks this as decisive.)
<prior biopsy>: important: Negative (The prior biopsy status is important because the panel protocol indicates this variable is decisive for the cohort criterion.)
<comorbidity>: noted: 3 on the problem list (The comorbidity level is noted because EXPERT-STRUCTURED marked it as important, and the panel protocol reflects this weighting.)
My confidence in the record as it stands is clear, as all required documents were retrieved and the findings directly support the panel's conclusion based on the fired cohort criterion.

MY SUGGESTION TO THE CHAIR
I suggest proceeding with the panel's recommendation of NO BIOPSY, as the retrieved evidence confirms the cohort criterion that supports this decision.

VERDICT: ready | SUGGEST: defer | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: NO BIOPSY   (confidence: clear)

63y male, PSA 0.44 ng/mL, PI-RADS 3, prior negative biopsy. No rising PSA density or lesion change justifies repeat biopsy. Low PSA density supports observation. Re-image in one year with low threshold for biopsy if lesion changes.

What carried weight: bx=important, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes, laboratory_results
